Sinphar Pharmaceutical Co.,Ltd. (TPE:1734)
Taiwan · Delayed Price · Currency is TWD 31.70
-0.25 (-0.78%)
Jul 30, 2026, 1:30 PM CST
Sinphar Pharmaceutical Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1,092 | 864.14 | 1,076 | 1,074 | 1,238 | 1,195 |
Short-Term Investments | 108.81 | 123.42 | 95.41 | - | - | 43.44 |
Trading Asset Securities | 7.08 | 7.07 | 6.96 | 6.66 | 6.66 | 6.66 |
Cash & Short-Term Investments | 1,208 | 994.63 | 1,178 | 1,081 | 1,244 | 1,245 |
Cash Growth | 7.36% | -15.57% | 8.96% | -13.11% | -0.05% | 4.24% |
Accounts Receivable | 688.87 | 713.86 | 641.9 | 643.47 | 685.19 | 592.97 |
Other Receivables | 35.14 | 35.58 | 34.81 | 34.27 | 31.43 | 29.15 |
Receivables | 724.01 | 749.44 | 676.71 | 677.73 | 716.62 | 622.12 |
Inventory | 804.71 | 761.14 | 751.35 | 876.9 | 804.31 | 820.62 |
Prepaid Expenses | 15.72 | 14.21 | 12.96 | 7.08 | 8.45 | 5.7 |
Other Current Assets | 4.85 | 9.82 | 5.3 | 5.75 | 4.86 | 10.03 |
Total Current Assets | 2,757 | 2,529 | 2,624 | 2,649 | 2,778 | 2,703 |
Property, Plant & Equipment | 3,252 | 3,222 | 3,285 | 3,247 | 3,139 | 3,224 |
Long-Term Investments | 50.5 | 52.68 | 54.64 | 22.21 | 24.7 | 20.36 |
Other Intangible Assets | 56.64 | 59.52 | 72.16 | 71.82 | 86.98 | 117.3 |
Long-Term Deferred Tax Assets | 181.41 | 195.49 | 185.37 | 170.86 | 52.11 | 74.88 |
Other Long-Term Assets | 123.17 | 94.28 | 76.62 | 90.71 | 103.65 | 81.24 |
Total Assets | 6,421 | 6,153 | 6,298 | 6,251 | 6,185 | 6,221 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 241.94 | 210.49 | 185.45 | 291.37 | 323.74 | 201.42 |
Short-Term Debt | 348 | 188 | 370 | 400 | 447 | 587 |
Current Portion of Long-Term Debt | 44.42 | 48.12 | 351.29 | 50.72 | 50.34 | 61.28 |
Current Portion of Leases | 0.86 | 0.58 | - | - | - | - |
Current Income Taxes Payable | 63.23 | 55.58 | 39.36 | 3.09 | 45.41 | 35.27 |
Current Unearned Revenue | 103.49 | 103.36 | 97.42 | 85.65 | 96.56 | 93.64 |
Other Current Liabilities | 160.88 | 405.36 | 379.29 | 373.87 | 482.86 | 555.88 |
Total Current Liabilities | 1,162 | 1,011 | 1,423 | 1,205 | 1,446 | 1,534 |
Long-Term Debt | 1,304 | 1,273 | 1,181 | 1,494 | 1,416 | 1,486 |
Long-Term Leases | 0.38 | 0.31 | - | - | - | - |
Pension & Post-Retirement Benefits | 16.54 | 22.27 | 15.09 | 35.55 | 35.98 | 50.89 |
Long-Term Deferred Tax Liabilities | - | 88.52 | 88.98 | 88.45 | 38.15 | 38.28 |
Other Long-Term Liabilities | 128.59 | 42.54 | 44 | 30.37 | 32.68 | 34.12 |
Total Liabilities | 2,612 | 2,438 | 2,752 | 2,853 | 2,968 | 3,144 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 1,902 | 1,902 | 1,811 | 1,677 | 1,677 | 1,677 |
Additional Paid-In Capital | 924.14 | 924.14 | 924.14 | 924.14 | 929.97 | 963.52 |
Retained Earnings | 786.82 | 713.02 | 648.43 | 634.15 | 444.41 | 210.68 |
Comprehensive Income & Other | -75.71 | -95.25 | -120.76 | -137.17 | -121.37 | -129.18 |
Total Common Equity | 3,537 | 3,444 | 3,263 | 3,098 | 2,930 | 2,722 |
Minority Interest | 271.36 | 271.3 | 282.98 | 299.54 | 286.62 | 354.94 |
Shareholders' Equity | 3,809 | 3,715 | 3,546 | 3,398 | 3,217 | 3,077 |
Total Liabilities & Equity | 6,421 | 6,153 | 6,298 | 6,251 | 6,185 | 6,221 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 1,698 | 1,510 | 1,902 | 1,945 | 1,913 | 2,134 |
Net Cash (Debt) | -490.48 | -515.14 | -724.46 | -863.71 | -668.74 | -889.35 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -2.57 | -2.70 | -3.80 | -4.53 | -3.51 | -4.68 |
Filing Date Shares Outstanding | 190.2 | 190.2 | 190.2 | 190.2 | 190.2 | 190.2 |
Total Common Shares Outstanding | 190.2 | 190.2 | 190.2 | 190.2 | 190.2 | 190.2 |
Working Capital | 1,594 | 1,518 | 1,202 | 1,444 | 1,333 | 1,169 |
Book Value Per Share | 18.60 | 18.11 | 17.16 | 16.29 | 15.41 | 14.31 |
Tangible Book Value | 3,481 | 3,384 | 3,191 | 3,027 | 2,843 | 2,605 |
Tangible Book Value Per Share | 18.30 | 17.79 | 16.78 | 15.91 | 14.95 | 13.70 |
Land | 740.36 | 717.58 | 717.58 | 717.58 | 717.58 | 717.58 |
Buildings | 3,268 | 3,224 | 3,195 | 2,978 | 2,927 | 2,882 |
Machinery | 2,492 | 2,461 | 2,350 | 2,195 | 2,027 | 1,960 |
Construction In Progress | 39.33 | 51.72 | 31.59 | 129.71 | 72.62 | 66.32 |